JUL 30, 2015 09:21 PM PDT

Hormones or Hunger?

Why do some people eat so much? It may be because of a hormone in the brain that controls eating for sheer pleasure, rather than hunger, according to new research at Rutgers University. The work could lead to targeting the brain to quell the growing obesity epidemic, according to the researchers. As Zhiping Pang, an assistant professor at Rutgers' Robert Wood Johnson Medical School, explained to Seth Augenstein of Laboratory Equipment, "Certain traits are very similar to drug addiction. If we can target one specific pathway in the brain, it would be fantastic" (http://www.biosciencetechnology.com/news/2015/07/hormone-brain-could-cause-overeating-says-rutgers-science?et_cid=4702150&et_rid=45505806&type=cta)
Hormones trigger overeating when the body is not really hungry.
According to the National Center for Biotechnology Information, in an article called "The hypothalamus, hormones, and hunger: alterations in human obesity and illness, by AP Goldstone, " Obesity is a major global epidemic, with over 300 million obese people worldwide, and nearly 1 billion overweight adults. Being overweight carries significant health risks, reduced quality of life, and impaired socioeconomic success, with profound consequences for health expenditure. The most successful treatment for obesity is gastric bypass surgery, which acts in part by reducing appetite through alterations in gut hormones. Circulating gut hormones, secreted or suppressed after eating food, act in the brain, particularly the hypothalamus, to alter hunger and fullness. Functional neuroimaging studies, using PET and fMRI, will also allow us to tease apart the hormonal and brain pathways responsible for controlling human appetite, and their defects in obesity" (http://www.ncbi.nlm.nih.gov/pubmed/16876568).

The hormone under investigation at Rutgers is called as glucagon-like peptide-1, or GLP-1. Prior research has indicated that the GLP-1 amino acids, secreted by the small intestine and the brain, "chemically tell the brain when the body is satisfied and should stop eating." The researchers explained the effects of the hormone in certain parts of mouse brains. When they reduced GLP-1 levels, the mice overate and ate fattier foods. When the researchers raised the hormone levels, the mice stayed away from fatty foods and only ate when they were hungry, according to an article that was published in the journal Cell Reports.

While GLP-1 therapies exist, including Saxenda, approved by the FDA in December, the drug is a full-body treatment that may cause side effects on the kidneys and liver. The Rutgers researchers are looking at neurons in the mesolimbic dopamine system, a reward circuit, that offer an acute target for new drugs, according to Pang. As he said, "If we can find a specific target, we would have a better therapy."

Additionally, the target could have further implications, Pang added. He explained that the area of the brain affected by GLP-1 is also the place where drug and alcohol addiction are neurologically centered. "The chemical foundations of urges could be subject to further investigation there, he said.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 04, 2018
Drug Discovery
SEP 04, 2018
Dopamine Provided Targeted Therapy for Neuropsychiatric Disorders
According to a study published in Molecular Psychiatry, research scientists at Columbia University Vagelos College of Physicians and Surgeons have brought ...
SEP 10, 2018
Neuroscience
SEP 10, 2018
Can Scientists Mimic The Effect of Exercise to Improve Memory?
Dementia is a growing problem for healthcare providers, patients, and families. The WHO estimates that globally more than 47 million people are living with...
OCT 04, 2018
Health & Medicine
OCT 04, 2018
Lead Paint Contamination in Military Housing Prompts Investigation
Lead paint is a serious health hazard. The sale of lead paint was banned in the United States in 1978, so homes built before the ban are likely to have at ...
OCT 07, 2018
Neuroscience
OCT 07, 2018
Marijuana and Anxiety
Like many neurotransmitters in the brain (dopamine, serotonin, etc.) the when and the where they are released in the brain is of utmost importance in deter...
NOV 05, 2018
Neuroscience
NOV 05, 2018
How does Brain's GPS work?
Understanding the brain cells involved in decoding and encoding naviagtional information....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Treating Restless Leg Syndrome (RLS)
A common condition of the nervous system, Restless Leg Syndrome (RLS) is the overwhelming urge to move the legs. Usually unpleasant symptoms, many RLS pati...
Loading Comments...